See the DrugPatentWatch profile for Besremi
What is Besremi (ropeginterferon alfa-2b), and what does “price in Australia” usually mean?
Besremi is a brand of ropeginterferon alfa-2b. When people ask “Besremi price Australia,” they usually want one of these:
- the out-of-pocket cost to a patient in Australia
- whether it is covered through the Pharmaceutical Benefits Scheme (PBS)
- the list price or subsidised price (often not the same as what a patient pays)
- how price changes under different patient circumstances (safety net, concessional status, etc.)
Is Besremi listed on the PBS in Australia (so patients pay less)?
The cost in Australia depends heavily on whether Besremi is available on the PBS and under what listing. PBS status determines whether patients pay a PBS copayment instead of the full market/list price.
I don’t have the provided sources needed to confirm whether Besremi is currently PBS-listed or to quote any Australian pricing.
If it is PBS-listed, what would patients typically pay?
If Besremi has a PBS listing, patient costs generally depend on:
- whether the patient is a concessional or general beneficiary
- the PBS safety net status
- the relevant PBS item and authority/eligibility criteria for the indication
Exact amounts change over time and are item- and status-specific, so quoting a number without a current PBS reference would likely be inaccurate.
If it is not PBS-listed (or for non-PBS use), what could patients expect?
Without PBS coverage, Australian out-of-pocket costs are typically closer to the medicine’s private market price, which can be high for specialty biologic/interferon therapies. The exact figure still requires current local pricing data.
Where to check the most accurate Besremi pricing in Australia
To get the correct, up-to-date “Besremi price Australia,” the most reliable sources are:
- the Australian PBS medicines database (for PBS availability and item-based pricing/cost to patients)
- Australian medicine pricing sources that publish the current listed price (if not PBS-listed)
- your treating clinician or dispensing pharmacy (they can check your PBS eligibility and quote the copayment)
If you tell me one detail, I can narrow what you need
Which pricing are you asking for?
1) Cost to a patient (general vs concessional, and PBS safety net or not)
2) PBS price/listing details (item number/authority requirements)
3) Private market/list price (not PBS)
If you share that plus the indication (e.g., primary/polycythaemia vera or related use), I can guide you to the exact place to confirm the current Australian cost.
Sources
No sources were provided with the question, so I can’t verify Besremi’s current Australian price or PBS listing.